Bentham Science Logo

Endocrine, Metabolic & Immune Disorders - Drug Targets

Formerly: Current Drug Targets - Immune, Endocrine & Metabolic Disorders

Volume 19, 8 Issues, 2019
ISSN: 2212-3873 (Online)
ISSN: 1871-5303 (Print)
This journal supports open access

Ranking and Category

  • 134th of 145 in

    Endocrinology & Metabolism

  • 148th of 158 in

    Immunology

  • 237th of 267 in

    Pharmacology & Pharmacy

Order Your Article Before Print

Contents

Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Volume 4 - Number 1

Melatonin Role in Experimental Arthritis

, 4(1): 1 - 10

Daniel P. Cardinali, Ana P. Garcia, Pilar Cano and Ana I. Esquifino


DOI: 10.2174/1568008043340071







HDL and Inflammation in Atherosclerosis

, 4(1): 51 - 57

Lukas E. Spieker, Frank Ruschitzka, Thomas F. Luscher and Georg Noll


DOI: 10.2174/1568005310404010051



The Paracrine Role Played by Interleukin-1α in the Testis

, 4(1): 67 - 74

K. Svechnikov, C. Petersen, T. Sultana, A. Wahlgren, C. Zetterstrom, E. Colon, C. Bornestaf and O. Soder


DOI: 10.2174/1568005310404010067







Editor-in-Chief

Emilio Jirillo
Department of Basic Medical Sciences Neuroscience and Sensory Organs
University of Bari “Aldo Moro”
Bari
Italy

Biography View Full Editorial Board

Journal History

Current Drug Targets - Immune, Endocrine & Metabolic Disorders was launched in 2001 and later renamed in 2006 as Endocrine, Metabolic & Immune Disorders - Drug Targets.

Related Journals

Related eBooks

eBooks Catalog